Kwok Fai Joseph Chow
Direktor/Vorstandsmitglied bei HUAKANG BIOMEDICAL HOLDINGS COMPANY LIMITED
Aktive Positionen von Kwok Fai Joseph Chow
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HUAKANG BIOMEDICAL HOLDINGS COMPANY LIMITED | Direktor/Vorstandsmitglied | 16.12.2020 | - |
| Independent Dir/Board Member | 16.12.2020 | - | |
DiagCor Bioscience, Inc. Ltd.
 DiagCor Bioscience, Inc. Ltd. Medical SpecialtiesHealth Technology DiagCor Bioscience, Inc. Ltd. develops and commercializes in vitro diagnostic kits and instruments. It offers a complete platform for commercial and clinical MDx diagnosis. The firm serves clinical diagnostic services markets in Latin America, Europe, Middle East and South East Asia. Its products include R2-M flow-through hybridization system, FT-PRO flow-through hybridization system, capture-PRO image capture system, Taigen VacEZor and FT-PRO auto system. The company was founded by Joseph Wing On Tam in 2006 and is headquartered in Hong Kong. | Technik-/Wissenschafts-/F&E-Leiter | 29.09.2014 | - |
| Corporate Officer/Principal | 17.02.2010 | 29.09.2014 | |
| Zhejiang Thunderbio Innovation Ltd. | Vorstandsvorsitzender | 01.04.2018 | - |
Karriereverlauf von Kwok Fai Joseph Chow
Ausbildung von Kwok Fai Joseph Chow
| Monash University | Undergraduate Degree |
| University of Hong Kong | Doctorate Degree |
Statistik
International
| Hong Kong | 4 |
| Australien | 2 |
| China | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HUAKANG BIOMEDICAL HOLDINGS COMPANY LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
DiagCor Bioscience, Inc. Ltd.
DiagCor Bioscience, Inc. Ltd. Medical SpecialtiesHealth Technology DiagCor Bioscience, Inc. Ltd. develops and commercializes in vitro diagnostic kits and instruments. It offers a complete platform for commercial and clinical MDx diagnosis. The firm serves clinical diagnostic services markets in Latin America, Europe, Middle East and South East Asia. Its products include R2-M flow-through hybridization system, FT-PRO flow-through hybridization system, capture-PRO image capture system, Taigen VacEZor and FT-PRO auto system. The company was founded by Joseph Wing On Tam in 2006 and is headquartered in Hong Kong. | Health Technology |
| Zhejiang Thunderbio Innovation Ltd. |
- Börse
- Insiders
- Kwok Fai Joseph Chow
- Erfahrung
